Status:
COMPLETED
The Impact of Sarcopenia on COPD Exacerbation Admission Outcome and Further Exacerbation Risk
Lead Sponsor:
Far Eastern Memorial Hospital
Conditions:
Sarcopenia
COPD Exacerbation
Eligibility:
All Genders
45+ years
Brief Summary
Chronic obstructive pulmonary disease (COPD) is more prevalent and has more impact on health status because of progressive air pollution, tobacco smoking and aging society. The COPD prevalence investi...
Eligibility Criteria
Inclusion
- Inclusion criteria: Patients more than 45 years-old, were admitted due to COPD exacerbation.
- COPD exacerbation criteria:
- acute worsening respiratory symptoms without any other causes, And
- Smoking more than 15 pack-years or the history of noxious gas exposure, And
- Spirometry reports suggests obstructive ventilatory defect (FEV1/FVC \<0.7) or
- Attending physicians diagnose as COPD by clinical parameters if spirometry data are not available while enrolling.
- Definite COPD exacerbation: fulfill 1、2、3 Probable COPD exacerbation: fulfill 1、2、4
- Exclusion criteria:
- Significant fluid retention such as edema, pleural effusion or ascites,
- Patients with permanent pacemaker or implantable cardioverter defibrillator ,
- Morbid obesity with BMI \>34
Exclusion
Key Trial Info
Start Date :
January 31 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 21 2020
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT04885933
Start Date
January 31 2018
End Date
June 21 2020
Last Update
May 13 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Far Eastern Memorial Hospital
New Taipei City, Taiwan, 220